Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
90.62
-1.03 (-1.12%)
At close: Aug 1, 2025, 4:00 PM
91.00
+0.38 (0.42%)
After-hours: Aug 1, 2025, 7:57 PM EDT

Company Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.

The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

It offers technology and data, bone cement, and surgical products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.

It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.

The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings logo
CountryUnited States
Founded1927
IndustryMedical Devices
SectorHealthcare
Employees17,000
CEOIvan Tornos

Contact Details

Address:
345 East Main Street
Warsaw, Indiana 46580
United States
Phone574 373 3333
Websitezimmerbiomet.com

Stock Details

Ticker SymbolZBH
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001136869
CUSIP Number98956P102
ISIN NumberUS98956P1021
Employer ID13-4151777
SIC Code3842

Key Executives

NamePosition
Ivan TornosPresident, Chief Executive Officer and Chairman of the Board
Suketu P. UpadhyayChief Financial Officer and Executive Vice President of Finance, Operations and Supply Chain
Sang YiGroup President of Asia Pacific
Wilfred van ZuilenGroup President of Europe, Middle East and Africa
Paul A. StellatoVice President, Controller and Chief Accounting Officer
Shaun BraunSenior Vice President and Chief Information and Technology Officer
David M. DeMartinoSenior Vice President of Investor Relations
Chad F. Phipps J.D.Senior Vice President, General Counsel and Secretary
Angela MainSenior Vice President, Global Chief Compliance Officer and Associate General Counsel of Asia Pacific
Kristen CardilloSenior Vice President and Chief Communications Officer

Latest SEC Filings

DateTypeTitle
Jul 14, 20258-KCurrent Report
Jun 30, 20258-KCurrent Report
Jun 20, 2025S-8Securities to be offered to employees in employee benefit plans
Jun 13, 2025144Filing
Jun 11, 2025144Filing
Jun 3, 20258-KCurrent Report
May 27, 20258-KCurrent Report
May 23, 2025SDForm - SD
May 6, 2025SCHEDULE 13G/AFiling
May 5, 202510-QQuarterly Report